In the study of bladder cancer, human gene expression profiling microarray sequencing combined with Ingenuity Pathway Analysis (IPA) were used to explore the changes of downstream gene expression and related signaling pathways in bladder urothelial carcinoma after CHAF1A knockdown. This evidence concerns the gene CHAF1A and urinary bladder cancer.